Shots: GI Innovations to receive $17M upfront, $1.2B as development & commercialization milestones along with royalties on sales of therapy Yuhan to get global rights (Ex-Japan) to develop and commercialize […]readmore
Tags : GI Innovation
Shots: GI to receive up front, milestones, and royalties on sales in China, including mainland China, Hong Kong, Macau, and Taiwan while Simcere will be responsible for all clinical development, […]readmore